Neurological immune-related adverse events of ipilimumab

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2010 • 14,016 citations

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

2011 • 4,304 citations

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

2006 • 812 citations

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

2007 • 673 citations

Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes

2009 • 275 citations

Ipilimumab: controversies in its development, utility and autoimmune adverse events

2009 • 223 citations

Anti-CTLA-4 antibody-induced Guillain–Barré syndrome in a melanoma patient

2011 • 171 citations

Ipilimumab-Induced Hypophysitis: MR Imaging Findings

2009 • 106 citations

Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab

2009 • 104 citations

Inflammatory Enteric Neuropathy With Severe Constipation After Ipilimumab Treatment for Melanoma

2009 • 79 citations

Severe meningo-radiculo-nevritis associated with ipilimumab

2012 • 67 citations

Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome

2005 • 31 citations

Factors affecting the susceptibility of the mouse pituitary gland to CD8 T‐cell‐mediated autoimmunity

2004 • 29 citations

Experimental Autoimmune Meningitis: A Novel Neurological Disease in CD28-Deficient Mice

1999 • 25 citations